460 related articles for article (PubMed ID: 11654187)
1. Shaping priorities in genetic medicine.
Boyle PJ
Hastings Cent Rep; 1995; 25(3 Suppl):S2-8. PubMed ID: 11654187
[TBL] [Abstract][Full Text] [Related]
2. Public priorities for genetic services.
Boyle PJ
Hastings Cent Rep; 1995; 25(3 Suppl):S1-2. PubMed ID: 11654183
[No Abstract] [Full Text] [Related]
3. Presentation on ethical issues associated with in utero gene therapy.
Fletcher JC
Hum Gene Ther; 1997 Jun; 8(9):1159-62. PubMed ID: 11644955
[No Abstract] [Full Text] [Related]
4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
5. The dispersion of genetic technologies and the law.
Clayton EW
Hastings Cent Rep; 1995; 25(3 Suppl):S13-5. PubMed ID: 11654184
[No Abstract] [Full Text] [Related]
6. Destructuring disability: rationing of health care and unfair discrimination against the sick.
Orentlicher D
Harv Civ Rights-Civil Lib Law Rev; 1996; 31(1):49-87. PubMed ID: 11660333
[No Abstract] [Full Text] [Related]
7. Health care rationing and disability rights.
Peters PG
Indiana Law J; 1995; 70(2):491-547. PubMed ID: 11660218
[No Abstract] [Full Text] [Related]
8. Gene dream fades away.
Coghlan A
New Sci; 1995 Nov; 148(2005):14-5. PubMed ID: 11656474
[No Abstract] [Full Text] [Related]
9. Gene therapy in mental retardation: ethical considerations.
Fletcher JC
Ment Retard Dev Disabil Res Rev; 1995; 1():7-13. PubMed ID: 11660293
[No Abstract] [Full Text] [Related]
10. Cost-benefit issues in U.S. national health legislation: the case of the End-Stage Renal Disease Program.
Kutner NG
Soc Probl; 1982 Oct; 30(1):51-64. PubMed ID: 11653717
[No Abstract] [Full Text] [Related]
11. Draft report to annual and central conferences, Dec 1990: an invitation to explore a frontier.
United Methodist Church. Genetic Science Task Force
Engage Soc Action; 1991 Jan; 4(1):17-27. PubMed ID: 11659313
[No Abstract] [Full Text] [Related]
12. In search of the perfect child: genetic testing and selective abortion.
Peters T
Christ Century; 1996 Oct; 113(31):1034-7. PubMed ID: 11656621
[No Abstract] [Full Text] [Related]
13. Coverage and care for the medically indigent: public and private options.
Bovbjerg RR; Kopit WG
Indiana Law Rev; 1986; 19(4):857-917. PubMed ID: 11650767
[No Abstract] [Full Text] [Related]
14. Ethical issues and perspectives in genetic technologies: an overview.
Mahowald MB
J Int Bioethique; 1990 Sep; 1(3):156-64. PubMed ID: 11651005
[No Abstract] [Full Text] [Related]
15. The Faustian cost of prenatal testing.
Kelly LB
Hum Life Rev; 1996; 22(1):13-22. PubMed ID: 11654307
[No Abstract] [Full Text] [Related]
16. Birthright or life sentence: controlling the threat of genetic testing.
Nobles K
South Calif Law Rev; 1992; 65(4):2081-128. PubMed ID: 11659655
[No Abstract] [Full Text] [Related]
17. Of diagnoses and discrimination: discriminatory nontreatment of infants with HIV infection.
Crossley MA
Columbia Law Rev; 1993 Nov; 93(7):1581-667. PubMed ID: 11659791
[No Abstract] [Full Text] [Related]
18. The Human Genome Project: bibliography of ethical, social, legal, and scientific aspects.
Arizona State University Center for the Study of Law, Science and Technology
Jurimetrics; 1992; 32(2):223-311. PubMed ID: 11659418
[No Abstract] [Full Text] [Related]
19. Promises and pitfalls: ethical dimensions of genetic engineering and anesthesiology.
Lysaught MT; Schwinn D
Semin Anesth; 1991 Sep; 10(3):141-56. PubMed ID: 11651352
[No Abstract] [Full Text] [Related]
20. Genetic testing, genetic medicine, and managed care.
Rothstein MA; Hoffman S
Wake Forest Law Rev; 1999; 34(3):849-88. PubMed ID: 12664926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
